Additional information on B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H2 2013 :- Nov 19, 2013
... 'B-
Cell Chronic Lymphocytic Leukemia -
Pipeline Review, H2
2013', provides an
overview of the indication's therapeutic
pipeline. This report
...- Nov 8, 2013
... Virtually all cases of acute lymphoblastic leukemia (ALL) are CD19 positive.
...
the treatment of B-
cell hematologic malignancies as of October
2013.
... with
previously untreated
chronic lymphocytic leukemia (CLL) and co-existing medical
conditions.
... Diabetic Macular Edema -
Pipeline Review, H2
2013.
- Oct 4, 2013
... (AML, Acute Myeloblastic
Leukemia) -
Pipeline Review, H2
2013',
... Gamida
Cell Ltd., Generex Biotechnology Corporation, Plexxikon
... Acute
Lymphocytic
Leukemia (ALL, Acute
Lymphoblastic Leukemia) -
Pipeline Review, H2
2013 ...
Chronic Myelocytic
Leukemia (CML,
Chronic Myeloid
Leukemia)
...- treatment of
chronic lymphocytic leukemia (CLL).
... B-
cells and is administered
by intravenous (IV)
... May
2013 and granted priority
review status to the BLA.
-
Chronic Lymphocytic Leukemia (CLL) -
Pipeline Review, H2
2013 Summary
Global
... Anti-CD22 Chimeric Antigen Receptor Expressing T-
Cells - Drug Profile
- Subsequently, FDA designated obinutuzumab as a breakthrough therapy for
CLL
and granted it priority
review with a PDUFA date of December 20,
2013.
-
pipeline 2013 ... review milestones. MAA. NDA/
... chronic lymphocytic leukaemia,
first line therapy & use in relapsed patients. III. Arzerra (ofatumumab)†. CD20
human monoclonal antibody diffuse large B
cell lymphoma (relapsed patients). III
.
- Jul 2, 2013
... GA101 is an investigational medicine designed to attack
cells that have a certain
... CLL is one of the most common forms of blood
cancer and in
2013, it is
... In
addition to GA101, Genentech's
pipeline of potential hematology
...Related links about B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H2 2013 :1.
Research and Markets: B-Cell Chronic Lymphocytic Leukemia ...2.
Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 20133.
Pipeline Report - Walgreens4.
FDA Grants Genentech's Obinutuzumab (GA101) Priority Review for ...5.
Obinutuzumab | pdl.com 
Recent comments
I have a lot of respect for
Finally a classy storage
This is a great cause to
This is certainly an
how many module I can Found
Thank You, TurtleDog! I'm
Weatherproof Electrical Box
This a great scoop. Cameras
I think it's wise for an
Funny, I'm the same way. I